Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling
2023Journal of the Egyptian National Cancer InstituteJournalOpen access
10.1186/s43046-023-00182-3Full text19 citations